E2D (p.Glu2Asp) variant of DCC (Netrin receptor DCC)
E2D (p.Glu2Asp) in DCC (Netrin receptor DCC) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
E2D (p.Glu2Asp) variant details
- p.Glu2Asp
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.16
- MetaSVM -0.73
- SIFT 0.02
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available